Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Zydus Wellness Investor Presentation: Key Takeaways

Zydus Wellness Q1 FY27 earnings presentation highlights strong double-digit growth in core portfolios like Sugar Free and Everyuth, despite weather-related headwinds impacting seasonal brands like Glucon-D and Nycil.

Highlights
Revenue growthDouble-digit in Sugar Free, Everyuth, and Nutralite portfolios.
MarginsEBITDA expansion in protein snacking; input costs managed through disciplined pricing.
Demand visibilityStrong in Q-commerce and e-commerce; premiumization trend driving higher-value shifts.
Management confidenceHigh; citing market leadership and outperforming category growth in most brands.

Growth

Sugar Free and Everyuth delivered double-digit growth. Everyuth moved from 5th to 4th rank in facial cleansing with 8.2% market share.

Outlook

Focus on scaling 'RiteBite Max Protein' and 'Complan NutriGro'. Strategic expansion into UK via Comfort Click Limited acquisition.

Risks

Unseasonal rainfall in North and East India impacted seasonal demand for Glucon-D and Nycil. Divergent commodity costs managed via pricing.

Last quarter's promises, checked

Delivered

  • Guided double-digit growth for Everyuth → delivered double-digit growth (= BEAT)
  • Guided market share expansion for Sugar Free → delivered 24 bps expansion (= BEAT)
  • Guided EPS accretion for Comfort Click in Q4 → delivered EPS accretive (= BEAT)

Partly delivered

  • Guided recovery in seasonal portfolio from May → delivered weather-related headwinds in Q1 (= PARTIAL)

Missed

  • Guided double-digit growth for seasonal brands → delivered 9.8% decline (= MISS)
  • Guided EBITDA margin of 17-18% → delivered lower than aspiration (= MISS)
Source

Investor Presentation filed with NSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.

Read the document ↗

Zydus Wellness Ltd: key numbers

Share price
₹520.60
Market cap
₹16,563 Cr
Revenue (annual)
₹3,961 Cr
Net profit (annual)
₹197.2 Cr
P/E (TTM)
88.0×Sector 43.4×
Promoter holding
69.64%+0.01% QoQ
FII holding
3.32%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zydus Wellness Ltd

All →
18:02 IST NSE
Management Change

Zydus Wellness Management Change

Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.

10:45 IST NSE
Price Movement Clarification

Zydus Wellness Price Movement Clarification

Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.

16:38 IST BSE
Other Announcement

Zydus Wellness Other Announcement

Zydus Wellness Ltd has received an ESG score of 71.7 from SES ESG Research Pvt. Ltd., improving from the previous score of 70.

16:53 IST NSE
Annual General Meeting

Zydus Wellness Annual General Meeting

Zydus Wellness Limited has filed the transcript of its 32nd Annual General Meeting held on August 4, 2026. This document records the proceedings of the meeting.